These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9925481)

  • 1. How stimulant drugs may calm hyperactivity.
    Marx J
    Science; 1999 Jan; 283(5400):306. PubMed ID: 9925481
    [No Abstract]   [Full Text] [Related]  

  • 2. "Model" behavior.
    Sarkis EH
    Science; 2000 Mar; 287(5461):2160-2. PubMed ID: 10744536
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin and the therapeutic effects of ritalin.
    Volkow ND; Gatley SJ; Fowler JS; Wang GJ; Swanson J
    Science; 2000 Apr; 288(5463):11. PubMed ID: 10766624
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
    Gainetdinov RR; Wetsel WC; Jones SR; Levin ED; Jaber M; Caron MG
    Science; 1999 Jan; 283(5400):397-401. PubMed ID: 9888856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Telang F; Maynard L; Logan J; Gatley SJ; Pappas N; Wong C; Vaska P; Zhu W; Swanson JM
    Am J Psychiatry; 2004 Jul; 161(7):1173-80. PubMed ID: 15229048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).
    Vles JS; Feron FJ; Hendriksen JG; Jolles J; van Kroonenburgh MJ; Weber WE
    Neuropediatrics; 2003 Apr; 34(2):77-80. PubMed ID: 12776228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
    Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
    Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of childhood disorders: XXIV. ADHD, part 8: hyperdopaminergic mice as an animal model of ADHD.
    Gainetdinov RR; Caron MG
    J Am Acad Child Adolesc Psychiatry; 2001 Mar; 40(3):380-2. PubMed ID: 11288782
    [No Abstract]   [Full Text] [Related]  

  • 10. The early development of child psychopharmacogenetics.
    Cook EH
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1478-81. PubMed ID: 10596246
    [No Abstract]   [Full Text] [Related]  

  • 11. The dopamine transporter: a crucial component regulating dopamine transmission.
    Jaber M; Jones S; Giros B; Caron MG
    Mov Disord; 1997 Sep; 12(5):629-33. PubMed ID: 9380041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An animal model of attention deficit hyperactivity disorder.
    Gainetdinov RR; Caron MG
    Mol Med Today; 2000 Jan; 6(1):43-4. PubMed ID: 10637574
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.
    Kirley A; Lowe N; Hawi Z; Mullins C; Daly G; Waldman I; McCarron M; O'Donnell D; Fitzgerald M; Gill M
    Am J Med Genet B Neuropsychiatr Genet; 2003 Aug; 121B(1):50-4. PubMed ID: 12898575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 15. Reward-enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention-deficit/hyperactivity disorder.
    Ide S; Ikekubo Y; Hua J; Takamatsu Y; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacol Rep; 2018 Sep; 38(3):149-153. PubMed ID: 30175528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavioral and pharmacological characteristics of mice lacking the dopamine transporter].
    Biala G
    Postepy Hig Med Dosw (Online); 2004; 58():560-4. PubMed ID: 15765018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-transporter density in patients with ADHD.
    Swanson JM
    Lancet; 2000 Apr; 355(9213):1461; author reply 1461-2. PubMed ID: 10791548
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
    Simchon Y; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):714-20. PubMed ID: 20493667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating problem children with stimulant drugs.
    Sroufe LA; Stewart MA
    N Engl J Med; 1973 Aug; 289(8):407-13. PubMed ID: 4146358
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate.
    Krause KH; Dresel S; Krause J; Kung HF; Tatsch K; Lochmüller H
    J Neurol; 2002 Aug; 249(8):1116-8. PubMed ID: 12420715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.